Autophagy-related protein expression was associated with BRAF V600E mutation in epilepsy associated glioneuronal tumors
Sign Up to like & getrecommendations! Published in 2017 at "Epilepsy Research"
DOI: 10.1016/j.eplepsyres.2017.06.006
Abstract: PURPOSE The aim of this study was to explore the expression level of autophagy-related proteins in epileptic patients with glioneuronal tumors (GNTs) and evaluate the association with clinicopathological features. MATERIALS AND METHODS We obtained the… read more here.
Keywords: braf v600e; expression; v600e mutation; autophagy related ... See more keywords
Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
Sign Up to like & getrecommendations! Published in 2017 at "Human pathology"
DOI: 10.1016/j.humpath.2016.09.010
Abstract: Capsular nevi (CN) are clusters of benign melanocytes situated in the capsule of lymph nodes and occur in up to 20% of lympadenectomy specimens. The molecular profile of CN in relation to prognostic parameters in… read more here.
Keywords: braf v600e; braf; v600e mutation; lymph nodes ... See more keywords
Desmoplastic non-infantile astrocytoma/ganglioglioma: rare low-grade tumor with frequent BRAF V600E mutation.
Sign Up to like & getrecommendations! Published in 2018 at "Human pathology"
DOI: 10.1016/j.humpath.2018.06.005
Abstract: Desmoplastic infantile astrocytoma/ganglioglioma (DIA/DIG) are rare primary glioneuronal tumors that comprise 0.5% to 1.0% of all intracranial tumors. While BRAF mutation is found in up to 50% of pediatric gangliogliomas, data for DIA/DIGs is limited.… read more here.
Keywords: braf v600e; astrocytoma ganglioglioma; braf; v600e mutation ... See more keywords
Identification of the BRAF V600E mutation in a patient with sclerosing pneumocytoma: A case report.
Sign Up to like & getrecommendations! Published in 2019 at "Lung cancer"
DOI: 10.1016/j.lungcan.2019.09.004
Abstract: OBJECTIVES Sclerosing pneumocytoma (sclerosing hemangioma, SP) is a rare benign tumor of the lung with a low risk of recurrence. The genomic profile of SP is not well-known. Here we report gene mutation findings in… read more here.
Keywords: braf v600e; sclerosing pneumocytoma; v600e mutation; mutation ... See more keywords
Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutation.
Sign Up to like & getrecommendations! Published in 2020 at "Lung cancer"
DOI: 10.1016/j.lungcan.2020.05.036
Abstract: INTRODUCTION Previous studies have reported an acquiredBRAF V600E mutation as a potential resistance mechanism to osimertinib treatment in advanced NSCLC patients with an activating mutation in EGFR. However, the therapeutic effect of combining dabrafenib and… read more here.
Keywords: braf v600e; dabrafenib trametinib; v600e mutation; v600e ... See more keywords
Frequency of BRAF V600E mutation in a group of Thai patients with ameloblastomas.
Sign Up to like & getrecommendations! Published in 2020 at "Oral surgery, oral medicine, oral pathology and oral radiology"
DOI: 10.1016/j.oooo.2020.06.002
Abstract: OBJECTIVE BRAF V600E mutation has recently been reported in a high proportion of ameloblastomas. This study was conducted to investigate the frequency of this mutation in ameloblastoma and unicystic ameloblastoma. The correlation between clinicopathologic data… read more here.
Keywords: frequency; braf v600e; braf; v600e mutation ... See more keywords
BRAF status as a predictive factor for response in isolated limb perfusion
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Hyperthermia"
DOI: 10.1080/02656736.2019.1601778
Abstract: Abstract Background: Isolated limb perfusion (ILP) is a treatment option for unresectable in-transit melanoma metastases of the extremities. Approximately two-thirds of the patients have a complete response, and known predictive factors mainly regard tumor burden.… read more here.
Keywords: isolated limb; limb perfusion; braf v600e; response ... See more keywords
Prevalence of the BRAF V600E mutation in Greek adults with Langerhans cell histiocytosis
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Hematology and Oncology"
DOI: 10.1080/08880018.2022.2029988
Abstract: Abstract Langerhans cell histiocytosis (LCH) is a rare inflammatory myeloid neoplasia with a broad spectrum of clinical manifestations. The activation of the MAP kinase pathway plays an integral role in its pathogenesis with genetic alterations… read more here.
Keywords: langerhans cell; prevalence; braf v600e; prevalence braf ... See more keywords
The Value of BRAF VE1 Immunoexpression in Pediatric Langerhans Cell Histiocytosis.
Sign Up to like & getrecommendations! Published in 2020 at "Fetal and pediatric pathology"
DOI: 10.1080/15513815.2020.1857483
Abstract: INTRODUCTION VE1 is a monoclonal antibody detecting mutant BRAF V600E protein by immunohistochemistry (IHC) with a high concordance rate with molecular analysis in many cancers. Materials and methods: BRAF V600E mutation was assessed on 94… read more here.
Keywords: braf v600e; value braf; braf; v600e mutation ... See more keywords
BRAF V600E mutation as a prognostic factor in cutaneous melanoma patients
Sign Up to like & getrecommendations! Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.13270
Abstract: The prognostic significance of BRAF mutations in the natural course of melanoma is controversial. The aim of study was to assess the prognostic significance of BRAF V600E mutation in cutaneous melanoma patients. A total of… read more here.
Keywords: cutaneous melanoma; braf v600e; v600e mutation; mutation ... See more keywords
BRAF V600E mutation in biliary proliferations associated with α1‐antitrypsin deficiency
Sign Up to like & getrecommendations! Published in 2017 at "Histopathology"
DOI: 10.1111/his.13083
Abstract: Both homozygous and heterozygous α1‐antitrypsin (AAT) deficiency patients are at risk of developing hepatocellular carcinoma (HCC), but also of developing cholangiocarcinoma and combined HCC and cholangiocarcinoma. The aim of our study is to report a… read more here.
Keywords: braf v600e; deficiency; v600e mutation;